Yuvezzi, a combination cholinergic agonist and alpha-adrenergic agonist, is now FDA-approved as a once-daily treatment for ...

HealthDay News — More than 31,000 nurses and health care workers walked off the job Monday morning at Kaiser Permanente ...

Ivonescimab is a first-in-class, investigational bispecific antibody targeting programmed cell death protein 1 and vascular endothelial growth factor.

Results from the iDose TR exchange trial showed a second administration and removal of the original implant was safe and well tolerated over 12 months.

HealthDay News — For the 5 leading causes of cancer-related death in people younger than 50 years, mortality decreased from 1990 through 2023, except for colorectal cancer (CRC), according to a ...

Many pediatricians are following vaccine guidance from the American Academy of Pediatrics, not the US Centers for Disease Control and Prevention ...

Darzalex Faspro is a subcutaneous formulation that combines daratumumab, a CD38-directed cytolytic antibody, and hyaluronidase, an endoglycosidase.

Litifilimab is a humanized IgG1 monoclonal antibody targeting the BDCA2 receptor to reduce proinflammatory mediators in cutaneous lupus erythematosus.

An AAV vector genome integration event associated with PLAG1 overexpression was identified in a preliminary analysis of the resected tumor.

Vaccination linked to lower inflammation scores, slower epigenetic, transcriptomic aging, and a lower composite biological aging score.

Spring & Mulberry announced January 14 that it has expanded its voluntary recall to include several additional chocolate flavors. The Raleigh, North Carolina–based company said the products may ...

HealthDay News — Federal health officials say a milk ingredient used in ByHeart infant formula may be tied to a botulism outbreak that has sickened dozens of babies across the US. On Friday, the Food ...